About this trial
The REgistry Study on multimodality trEAtment foR Cerebral Hemorrhage (RESEARCH) aims to address these challenges by establishing a comprehensive national registry. This initiative will collect detailed, longitudinal data on the clinical characteristics, treatment modalities, and outcomes of patients with ICH across various regions. By leveraging a wide array of treatment data - including medical management, surgical interventions, and rehabilitative strategies - the RESEARCH registry intends to provide a granular view of current treatment landscapes and their direct impact on patient recovery and quality of life.
Eligibility criteria
Qualifiers
Cerebral hemorrhage
Disqualifiers
None
Trial design
Treatments tested in this trial
- medical management, surgical interventions, and rehabilitative strategies
Treatment groups
Locations
Sponsors and collaborators
Tao Liu
Lead sponsor
The George Institute
Sponsor institution
Tianjin Medical University General Hospital
Collaborator
Xuanwu Hospital, Beijing
Collaborator